Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo

Bruce L Geller1, Kimberly Marshall-Batty, Frederick J Schnell

  • 1Department of Microbiology, Oregon State University.

Abstract

Insights

Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) targeting essential genes in Acinetobacter species show promise as a new antibiotic. These PPMOs were effective in vitro and in vivo, increasing survival in a mouse model of infection.

Area of Science:

  • Microbiology
  • Antimicrobial Research
  • Molecular Biology

Background:

  • Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMOs) are synthetic nucleic acid analogs designed to silence specific gene expression.
  • Acinetobacter species, including A. lwoffii and A. baumannii, are significant opportunistic pathogens, often exhibiting multidrug resistance.

Purpose of the Study:

  • To evaluate the in vitro and in vivo efficacy of PPMOs targeting essential genes in Acinetobacter lwoffii and Acinetobacter baumannii.
  • To assess the potential of PPMOs as a therapeutic strategy against multidrug-resistant Acinetobacter infections.

Main Methods:

  • In vitro studies involved minimum inhibitory concentration (MIC) and viability assays to determine PPMO effectiveness.
  • In vivo efficacy was assessed using murine pulmonary infection models with intranasal PPMO administration.
  • Survival rates, inflammation, and bacterial lung burden were measured in treated and control mice.

Main Results:

  • PPMOs demonstrated bactericidal activity with MICs in a clinically relevant range (0.1 to 64 µM).
  • The PPMO (RXR)4-AcpP, targeting the acpP gene, significantly reduced bacterial viability.
  • Mice treated with (RXR)4-AcpP showed increased survival, reduced lung inflammation, and lower bacterial burden, even with delayed treatment.

Conclusions:

  • PPMOs targeting essential genes are effective bactericidal agents against Acinetobacter species.
  • (RXR)4-AcpP significantly improved survival in a mouse model of Acinetobacter infection.
  • PPMOs represent a promising therapeutic approach for combating multidrug-resistant Acinetobacter infections.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
966
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
13.4K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
24.4K
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73